Skip to Content
Headshot of W. Nicholson Price


Ariel Dora Stern, Avi Goldfarb, Timo Minssen, and W. Nicholson Price II (Former Academic Fellow)
NEJM Catalyst
March 16, 2022

Read the Full Article.

Despite enthusiasm about the potential to apply artificial intelligence (AI) to medicine and health care delivery, adoption remains tepid, even for the most compelling technologies. In this article, the authors focus on one set of challenges to AI adoption: those related to liability. Well-designed AI liability insurance can mitigate predictable liability risks and uncertainties in a way that is aligned with the interests of health care’s main stakeholders, including patients, physicians, and health care organization leadership. A market for AI insurance will encourage the use of high-quality AI, because insurers will be most keen to underwrite those products that are demonstrably safe and effective. As such, well-designed AI insurance products are likely to reduce the uncertainty associated with liability risk for both manufacturers — including developers of software as a medical device — and clinician users and thereby increase innovation, competition, adoption, and trust in beneficial technological advances.

Read the Full Article.

Tags

bioethics   health law policy